APO Research
Talk to an analyst

APO RESEARCH · REPORT

PECAM-1 Antibody

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global PECAM-1 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025198 pages

Choose your research edition.

Industry ResearchPECAM-1 Antibody Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal PECAM-1 Antibody Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal PECAM-1 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PECAM-1 Antibody Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal PECAM-1 Antibody Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global PECAM-1 Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for PECAM-1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for PECAM-1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PECAM-1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for PECAM-1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of PECAM-1 Antibody include Thermo Fisher, YO Proteins, US Biological, SICGEN, Santa Cruz Biotechnology, Rockland Immunochemicals, R&D Systems, Proteintech Group and OriGene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global PECAM-1 Antibody market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of PECAM-1 Antibody and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents PECAM-1 Antibody sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the PECAM-1 Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.

PECAM-1 Antibody Segment by Company

Thermo Fisher

YO Proteins

US Biological

SICGEN

Santa Cruz Biotechnology

Rockland Immunochemicals

R&D Systems

Proteintech Group

OriGene

Novus Biologicals

Miltenyi Biotec

MilliporeSigma

LifeSpan Biosciences

Enzo Life Sciences

Dianova

Creative Biomart

Boster

Bon Opus Biosciences

Bio-Rad

BioLegend

Abnova

Abeomics

Abcam

PECAM-1 Antibody Segment by Type

Mouse

Rabbit

Others

PECAM-1 Antibody Segment by Application

Laboratory

Hospital

Others

PECAM-1 Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PECAM-1 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PECAM-1 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PECAM-1 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the PECAM-1 Antibody market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of PECAM-1 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of PECAM-1 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of PECAM-1 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. PECAM-1 Antibody Industry Trends Table 2. PECAM-1 Antibody Industry Drivers Table 3. PECAM-1 Antibody Industry Opportunities and Challenges Table 4. PECAM-1 Antibody Industry Restraints Table 5. Global PECAM-1 Antibody Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global PECAM-1 Antibody Revenue Market Share by Manufacturers (2021-2026) Table 7. Global PECAM-1 Antibody Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global PECAM-1 Antibody Sales Market Share by Manufacturers Table 9. Global PECAM-1 Antibody Average Sales Price (US$/g) of Manufacturers (2021-2026) Table 10. Global PECAM-1 Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global PECAM-1 Antibody Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global PECAM-1 Antibody Manufacturers, Product Type & Application Table 13. Global PECAM-1 Antibody Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global PECAM-1 Antibody by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Mouse Table 17. Major Manufacturers of Rabbit Table 18. Major Manufacturers of Others Table 19. Global PECAM-1 Antibody Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global PECAM-1 Antibody Sales by Type (2021-2026) & (Kg) Table 21. Global PECAM-1 Antibody Sales by Type (2027-2032) & (Kg) Table 22. Global PECAM-1 Antibody Sales Market Share by Type (2021-2026) Table 23. Global PECAM-1 Antibody Sales Market Share by Type (2027-2032) Table 24. Global PECAM-1 Antibody Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 25. Global PECAM-1 Antibody Revenue by Type (2021-2026) & (Kg) Table 26. Global PECAM-1 Antibody Revenue by Type (2027-2032) & (Kg) Table 27. Global PECAM-1 Antibody Revenue Market Share by Type (2021-2026) Table 28. Global PECAM-1 Antibody Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Laboratory Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Others Table 32. Global PECAM-1 Antibody Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 33. Global PECAM-1 Antibody Sales by Application (2021-2026) & (Kg) Table 34. Global PECAM-1 Antibody Sales by Application (2027-2032) & (Kg) Table 35. Global PECAM-1 Antibody Sales Market Share by Application (2021-2026) Table 36. Global PECAM-1 Antibody Sales Market Share by Application (2027-2032) Table 37. Global PECAM-1 Antibody Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 38. Global PECAM-1 Antibody Revenue by Application (2021-2026) & (Kg) Table 39. Global PECAM-1 Antibody Revenue by Application (2027-2032) & (Kg) Table 40. Global PECAM-1 Antibody Revenue Market Share by Application (2021-2026) Table 41. Global PECAM-1 Antibody Revenue Market Share by Application (2027-2032) Table 42. Global PECAM-1 Antibody Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 43. Global PECAM-1 Antibody Sales by Region (2021-2026) & (Kg) Table 44. Global PECAM-1 Antibody Sales Market Share by Region (2021-2026) Table 45. Global PECAM-1 Antibody Sales Forecasted by Region (2027-2032) & (Kg) Table 46. Global PECAM-1 Antibody Sales Forecasted Market Share by Region (2027-2032) Table 47. North America PECAM-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 48. North America PECAM-1 Antibody Sales by Country (2021-2026) & (Kg) Table 49. North America PECAM-1 Antibody Sales by Country (2027-2032) & (Kg) Table 50. Europe PECAM-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 51. Europe PECAM-1 Antibody Sales by Country (2021-2026) & (Kg) Table 52. Europe PECAM-1 Antibody Sales by Country (2027-2032) & (Kg) Table 53. Asia Pacific PECAM-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 54. Asia Pacific PECAM-1 Antibody Sales by Country (2021-2026) & (Kg) Table 55. Asia Pacific PECAM-1 Antibody Sales by Country (2027-2032) & (Kg) Table 56. South America, Middle East and Africa PECAM-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 57. South America, Middle East and Africa PECAM-1 Antibody Sales by Country (2021-2026) & (Kg) Table 58. South America, Middle East and Africa PECAM-1 Antibody Sales by Country (2027-2032) & (Kg) Table 59. Global PECAM-1 Antibody Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global PECAM-1 Antibody Revenue by Region (2021-2026) & (US$ Million) Table 61. Global PECAM-1 Antibody Revenue by Region (2027-2032) & (US$ Million) Table 62. Global PECAM-1 Antibody Revenue Market Share by Region (2021-2026) Table 63. Global PECAM-1 Antibody Revenue Market Share by Region (2027-2032) Table 64. Thermo Fisher Company Information Table 65. Thermo Fisher Business Overview Table 66. Thermo Fisher PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Thermo Fisher PECAM-1 Antibody Product Portfolio Table 68. Thermo Fisher Recent Development Table 69. YO Proteins Company Information Table 70. YO Proteins Business Overview Table 71. YO Proteins PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. YO Proteins PECAM-1 Antibody Product Portfolio Table 73. YO Proteins Recent Development Table 74. US Biological Company Information Table 75. US Biological Business Overview Table 76. US Biological PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. US Biological PECAM-1 Antibody Product Portfolio Table 78. US Biological Recent Development Table 79. SICGEN Company Information Table 80. SICGEN Business Overview Table 81. SICGEN PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. SICGEN PECAM-1 Antibody Product Portfolio Table 83. SICGEN Recent Development Table 84. Santa Cruz Biotechnology Company Information Table 85. Santa Cruz Biotechnology Business Overview Table 86. Santa Cruz Biotechnology PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Santa Cruz Biotechnology PECAM-1 Antibody Product Portfolio Table 88. Santa Cruz Biotechnology Recent Development Table 89. Rockland Immunochemicals Company Information Table 90. Rockland Immunochemicals Business Overview Table 91. Rockland Immunochemicals PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Rockland Immunochemicals PECAM-1 Antibody Product Portfolio Table 93. Rockland Immunochemicals Recent Development Table 94. R&D Systems Company Information Table 95. R&D Systems Business Overview Table 96. R&D Systems PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. R&D Systems PECAM-1 Antibody Product Portfolio Table 98. R&D Systems Recent Development Table 99. Proteintech Group Company Information Table 100. Proteintech Group Business Overview Table 101. Proteintech Group PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Proteintech Group PECAM-1 Antibody Product Portfolio Table 103. Proteintech Group Recent Development Table 104. OriGene Company Information Table 105. OriGene Business Overview Table 106. OriGene PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. OriGene PECAM-1 Antibody Product Portfolio Table 108. OriGene Recent Development Table 109. Novus Biologicals Company Information Table 110. Novus Biologicals Business Overview Table 111. Novus Biologicals PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Novus Biologicals PECAM-1 Antibody Product Portfolio Table 113. Novus Biologicals Recent Development Table 114. Miltenyi Biotec Company Information Table 115. Miltenyi Biotec Business Overview Table 116. Miltenyi Biotec PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Miltenyi Biotec PECAM-1 Antibody Product Portfolio Table 118. Miltenyi Biotec Recent Development Table 119. MilliporeSigma Company Information Table 120. MilliporeSigma Business Overview Table 121. MilliporeSigma PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. MilliporeSigma PECAM-1 Antibody Product Portfolio Table 123. MilliporeSigma Recent Development Table 124. LifeSpan Biosciences Company Information Table 125. LifeSpan Biosciences Business Overview Table 126. LifeSpan Biosciences PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. LifeSpan Biosciences PECAM-1 Antibody Product Portfolio Table 128. LifeSpan Biosciences Recent Development Table 129. Enzo Life Sciences Company Information Table 130. Enzo Life Sciences Business Overview Table 131. Enzo Life Sciences PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Enzo Life Sciences PECAM-1 Antibody Product Portfolio Table 133. Enzo Life Sciences Recent Development Table 134. Dianova Company Information Table 135. Dianova Business Overview Table 136. Dianova PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Dianova PECAM-1 Antibody Product Portfolio Table 138. Dianova Recent Development Table 139. Creative Biomart Company Information Table 140. Creative Biomart Business Overview Table 141. Creative Biomart PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Creative Biomart PECAM-1 Antibody Product Portfolio Table 143. Creative Biomart Recent Development Table 144. Boster Company Information Table 145. Boster Business Overview Table 146. Boster PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Boster PECAM-1 Antibody Product Portfolio Table 148. Boster Recent Development Table 149. Bon Opus Biosciences Company Information Table 150. Bon Opus Biosciences Business Overview Table 151. Bon Opus Biosciences PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Bon Opus Biosciences PECAM-1 Antibody Product Portfolio Table 153. Bon Opus Biosciences Recent Development Table 154. Bio-Rad Company Information Table 155. Bio-Rad Business Overview Table 156. Bio-Rad PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Bio-Rad PECAM-1 Antibody Product Portfolio Table 158. Bio-Rad Recent Development Table 159. BioLegend Company Information Table 160. BioLegend Business Overview Table 161. BioLegend PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. BioLegend PECAM-1 Antibody Product Portfolio Table 163. BioLegend Recent Development Table 164. Abnova Company Information Table 165. Abnova Business Overview Table 166. Abnova PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 167. Abnova PECAM-1 Antibody Product Portfolio Table 168. Abnova Recent Development Table 169. Abeomics Company Information Table 170. Abeomics Business Overview Table 171. Abeomics PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 172. Abeomics PECAM-1 Antibody Product Portfolio Table 173. Abeomics Recent Development Table 174. Abcam Company Information Table 175. Abcam Business Overview Table 176. Abcam PECAM-1 Antibody Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 177. Abcam PECAM-1 Antibody Product Portfolio Table 178. Abcam Recent Development Table 179. Key Raw Materials Table 180. Raw Materials Key Suppliers Table 181. PECAM-1 Antibody Distributors List Table 182. PECAM-1 Antibody Customers List Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources Table 186. Primary Sources List of Figures Figure 1. PECAM-1 Antibody Product Image Figure 2. Global PECAM-1 Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PECAM-1 Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global PECAM-1 Antibody Sales (2021-2032) & (Kg) Figure 5. Global PECAM-1 Antibody Average Price (US$/g) & (2021-2032) Figure 6. Global Top 5 and 10 PECAM-1 Antibody Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Mouse Image Figure 9. Rabbit Image Figure 10. Others Image Figure 11. Global PECAM-1 Antibody Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global PECAM-1 Antibody Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global PECAM-1 Antibody Sales Market Share by Type (2021-2032) Figure 14. Global PECAM-1 Antibody Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 15. Global PECAM-1 Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global PECAM-1 Antibody Revenue Market Share by Type (2021-2032) Figure 17. Laboratory Image Figure 18. Hospital Image Figure 19. Others Image Figure 20. Global PECAM-1 Antibody Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global PECAM-1 Antibody Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global PECAM-1 Antibody Sales Market Share by Application (2021-2032) Figure 23. Global PECAM-1 Antibody Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 24. Global PECAM-1 Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global PECAM-1 Antibody Revenue Market Share by Application (2021-2032) Figure 26. North America PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 27. North America PECAM-1 Antibody Sales Market Share by Country (2021-2032) Figure 28. U.S. PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Canada PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Mexico PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Europe PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 32. Europe PECAM-1 Antibody Sales Market Share by Country (2021-2032) Figure 33. Germany PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 34. France PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 35. U.K. PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Italy PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Netherlands PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Asia Pacific PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Asia Pacific PECAM-1 Antibody Sales Market Share by Country (2021-2032) Figure 40. China PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Japan PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 42. South Korea PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 43. Southeast Asia PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 44. India PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 45. Australia PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 46. South America, Middle East and Africa PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 47. South America, Middle East and Africa PECAM-1 Antibody Sales Market Share by Country (2021-2032) Figure 48. Brazil PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 49. South Africa PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Saudi Arabia PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 51. Turkey PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 52. Argentina PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 53. UAE PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Egypt PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 55. Chile PECAM-1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 56. Global PECAM-1 Antibody Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global PECAM-1 Antibody Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Figure 59. North America PECAM-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Figure 61. Europe PECAM-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific PECAM-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa PECAM-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. PECAM-1 Antibody Value Chain Figure 67. Manufacturing Cost Structure Figure 68. PECAM-1 Antibody Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Mouse
  • Rabbit
  • Others
Applications
  • Laboratory
  • Hospital
  • Others
Companies covered
  • Thermo Fisher
  • YO Proteins
  • US Biological
  • SICGEN
  • Santa Cruz Biotechnology
  • Rockland Immunochemicals
  • R&D Systems
  • Proteintech Group
  • OriGene
  • Novus Biologicals
  • Miltenyi Biotec
  • MilliporeSigma
  • LifeSpan Biosciences
  • Enzo Life Sciences
  • Dianova
  • Creative Biomart
  • Boster
  • Bon Opus Biosciences
  • Bio-Rad
  • BioLegend
  • Abnova
  • Abeomics
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global PECAM-1 Antibody Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global PECAM-1 Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global PECAM-1 Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global PECAM-1 Antibody Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global PECAM-1 Antibody Market Dynamics
  1. 2.1 PECAM-1 Antibody Industry Trends
  2. 2.2 PECAM-1 Antibody Industry Drivers
  3. 2.3 PECAM-1 Antibody Industry Opportunities and Challenges
  4. 2.4 PECAM-1 Antibody Industry Restraints
3 PECAM-1 Antibody Market by Manufacturers
  1. 3.1 Global PECAM-1 Antibody Revenue by Manufacturers (2021-2026)
  2. 3.2 Global PECAM-1 Antibody Sales by Manufacturers (2021-2026)
  3. 3.3 Global PECAM-1 Antibody Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global PECAM-1 Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global PECAM-1 Antibody Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global PECAM-1 Antibody Manufacturers, Product Type & Application
  7. 3.7 Global PECAM-1 Antibody Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global PECAM-1 Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 PECAM-1 Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 PECAM-1 Antibody Tier 1, Tier 2, and Tier 3
4 PECAM-1 Antibody Market by Type
  1. 4.1 PECAM-1 Antibody Type Introduction
  2. 4.1.1 Mouse
  3. 4.1.2 Rabbit
  4. 4.1.3 Others
  5. 4.2 Global PECAM-1 Antibody Sales by Type
  6. 4.2.1 Global PECAM-1 Antibody Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global PECAM-1 Antibody Sales by Type (2021-2032)
  8. 4.2.3 Global PECAM-1 Antibody Sales Market Share by Type (2021-2032)
  9. 4.3 Global PECAM-1 Antibody Revenue by Type
  10. 4.3.1 Global PECAM-1 Antibody Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global PECAM-1 Antibody Revenue by Type (2021-2032)
  12. 4.3.3 Global PECAM-1 Antibody Revenue Market Share by Type (2021-2032)
5 PECAM-1 Antibody Market by Application
  1. 5.1 PECAM-1 Antibody Application Introduction
  2. 5.1.1 Laboratory
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global PECAM-1 Antibody Sales by Application
  6. 5.2.1 Global PECAM-1 Antibody Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global PECAM-1 Antibody Sales by Application (2021-2032)
  8. 5.2.3 Global PECAM-1 Antibody Sales Market Share by Application (2021-2032)
  9. 5.3 Global PECAM-1 Antibody Revenue by Application
  10. 5.3.1 Global PECAM-1 Antibody Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global PECAM-1 Antibody Revenue by Application (2021-2032)
  12. 5.3.3 Global PECAM-1 Antibody Revenue Market Share by Application (2021-2032)
6 Global PECAM-1 Antibody Sales by Region
  1. 6.1 Global PECAM-1 Antibody Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global PECAM-1 Antibody Sales by Region (2021-2032)
  3. 6.2.1 Global PECAM-1 Antibody Sales by Region (2021-2026)
  4. 6.2.2 Global PECAM-1 Antibody Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America PECAM-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America PECAM-1 Antibody Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe PECAM-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe PECAM-1 Antibody Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific PECAM-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific PECAM-1 Antibody Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa PECAM-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa PECAM-1 Antibody Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global PECAM-1 Antibody Revenue by Region
  1. 7.1 Global PECAM-1 Antibody Revenue by Region
  2. 7.1.1 Global PECAM-1 Antibody Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global PECAM-1 Antibody Revenue by Region (2021-2026)
  4. 7.1.3 Global PECAM-1 Antibody Revenue by Region (2027-2032)
  5. 7.1.4 Global PECAM-1 Antibody Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America PECAM-1 Antibody Revenue (2021-2032)
  8. 7.2.2 North America PECAM-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe PECAM-1 Antibody Revenue (2021-2032)
  11. 7.3.2 Europe PECAM-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific PECAM-1 Antibody Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific PECAM-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa PECAM-1 Antibody Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa PECAM-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher
  2. 8.1.1 Thermo Fisher Company Information
  3. 8.1.2 Thermo Fisher Business Overview
  4. 8.1.3 Thermo Fisher PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher PECAM-1 Antibody Product Portfolio
  6. 8.1.5 Thermo Fisher Recent Developments
  7. 8.2 YO Proteins
  8. 8.2.1 YO Proteins Company Information
  9. 8.2.2 YO Proteins Business Overview
  10. 8.2.3 YO Proteins PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 YO Proteins PECAM-1 Antibody Product Portfolio
  12. 8.2.5 YO Proteins Recent Developments
  13. 8.3 US Biological
  14. 8.3.1 US Biological Company Information
  15. 8.3.2 US Biological Business Overview
  16. 8.3.3 US Biological PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 US Biological PECAM-1 Antibody Product Portfolio
  18. 8.3.5 US Biological Recent Developments
  19. 8.4 SICGEN
  20. 8.4.1 SICGEN Company Information
  21. 8.4.2 SICGEN Business Overview
  22. 8.4.3 SICGEN PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SICGEN PECAM-1 Antibody Product Portfolio
  24. 8.4.5 SICGEN Recent Developments
  25. 8.5 Santa Cruz Biotechnology
  26. 8.5.1 Santa Cruz Biotechnology Company Information
  27. 8.5.2 Santa Cruz Biotechnology Business Overview
  28. 8.5.3 Santa Cruz Biotechnology PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Santa Cruz Biotechnology PECAM-1 Antibody Product Portfolio
  30. 8.5.5 Santa Cruz Biotechnology Recent Developments
  31. 8.6 Rockland Immunochemicals
  32. 8.6.1 Rockland Immunochemicals Company Information
  33. 8.6.2 Rockland Immunochemicals Business Overview
  34. 8.6.3 Rockland Immunochemicals PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Rockland Immunochemicals PECAM-1 Antibody Product Portfolio
  36. 8.6.5 Rockland Immunochemicals Recent Developments
  37. 8.7 R&D Systems
  38. 8.7.1 R&D Systems Company Information
  39. 8.7.2 R&D Systems Business Overview
  40. 8.7.3 R&D Systems PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 R&D Systems PECAM-1 Antibody Product Portfolio
  42. 8.7.5 R&D Systems Recent Developments
  43. 8.8 Proteintech Group
  44. 8.8.1 Proteintech Group Company Information
  45. 8.8.2 Proteintech Group Business Overview
  46. 8.8.3 Proteintech Group PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Proteintech Group PECAM-1 Antibody Product Portfolio
  48. 8.8.5 Proteintech Group Recent Developments
  49. 8.9 OriGene
  50. 8.9.1 OriGene Company Information
  51. 8.9.2 OriGene Business Overview
  52. 8.9.3 OriGene PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 OriGene PECAM-1 Antibody Product Portfolio
  54. 8.9.5 OriGene Recent Developments
  55. 8.10 Novus Biologicals
  56. 8.10.1 Novus Biologicals Company Information
  57. 8.10.2 Novus Biologicals Business Overview
  58. 8.10.3 Novus Biologicals PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novus Biologicals PECAM-1 Antibody Product Portfolio
  60. 8.10.5 Novus Biologicals Recent Developments
  61. 8.11 Miltenyi Biotec
  62. 8.11.1 Miltenyi Biotec Company Information
  63. 8.11.2 Miltenyi Biotec Business Overview
  64. 8.11.3 Miltenyi Biotec PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Miltenyi Biotec PECAM-1 Antibody Product Portfolio
  66. 8.11.5 Miltenyi Biotec Recent Developments
  67. 8.12 MilliporeSigma
  68. 8.12.1 MilliporeSigma Company Information
  69. 8.12.2 MilliporeSigma Business Overview
  70. 8.12.3 MilliporeSigma PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 MilliporeSigma PECAM-1 Antibody Product Portfolio
  72. 8.12.5 MilliporeSigma Recent Developments
  73. 8.13 LifeSpan Biosciences
  74. 8.13.1 LifeSpan Biosciences Company Information
  75. 8.13.2 LifeSpan Biosciences Business Overview
  76. 8.13.3 LifeSpan Biosciences PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 LifeSpan Biosciences PECAM-1 Antibody Product Portfolio
  78. 8.13.5 LifeSpan Biosciences Recent Developments
  79. 8.14 Enzo Life Sciences
  80. 8.14.1 Enzo Life Sciences Company Information
  81. 8.14.2 Enzo Life Sciences Business Overview
  82. 8.14.3 Enzo Life Sciences PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Enzo Life Sciences PECAM-1 Antibody Product Portfolio
  84. 8.14.5 Enzo Life Sciences Recent Developments
  85. 8.15 Dianova
  86. 8.15.1 Dianova Company Information
  87. 8.15.2 Dianova Business Overview
  88. 8.15.3 Dianova PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Dianova PECAM-1 Antibody Product Portfolio
  90. 8.15.5 Dianova Recent Developments
  91. 8.16 Creative Biomart
  92. 8.16.1 Creative Biomart Company Information
  93. 8.16.2 Creative Biomart Business Overview
  94. 8.16.3 Creative Biomart PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Creative Biomart PECAM-1 Antibody Product Portfolio
  96. 8.16.5 Creative Biomart Recent Developments
  97. 8.17 Boster
  98. 8.17.1 Boster Company Information
  99. 8.17.2 Boster Business Overview
  100. 8.17.3 Boster PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Boster PECAM-1 Antibody Product Portfolio
  102. 8.17.5 Boster Recent Developments
  103. 8.18 Bon Opus Biosciences
  104. 8.18.1 Bon Opus Biosciences Company Information
  105. 8.18.2 Bon Opus Biosciences Business Overview
  106. 8.18.3 Bon Opus Biosciences PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Bon Opus Biosciences PECAM-1 Antibody Product Portfolio
  108. 8.18.5 Bon Opus Biosciences Recent Developments
  109. 8.19 Bio-Rad
  110. 8.19.1 Bio-Rad Company Information
  111. 8.19.2 Bio-Rad Business Overview
  112. 8.19.3 Bio-Rad PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Bio-Rad PECAM-1 Antibody Product Portfolio
  114. 8.19.5 Bio-Rad Recent Developments
  115. 8.20 BioLegend
  116. 8.20.1 BioLegend Company Information
  117. 8.20.2 BioLegend Business Overview
  118. 8.20.3 BioLegend PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 BioLegend PECAM-1 Antibody Product Portfolio
  120. 8.20.5 BioLegend Recent Developments
  121. 8.21 Abnova
  122. 8.21.1 Abnova Company Information
  123. 8.21.2 Abnova Business Overview
  124. 8.21.3 Abnova PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Abnova PECAM-1 Antibody Product Portfolio
  126. 8.21.5 Abnova Recent Developments
  127. 8.22 Abeomics
  128. 8.22.1 Abeomics Company Information
  129. 8.22.2 Abeomics Business Overview
  130. 8.22.3 Abeomics PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Abeomics PECAM-1 Antibody Product Portfolio
  132. 8.22.5 Abeomics Recent Developments
  133. 8.23 Abcam
  134. 8.23.1 Abcam Company Information
  135. 8.23.2 Abcam Business Overview
  136. 8.23.3 Abcam PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Abcam PECAM-1 Antibody Product Portfolio
  138. 8.23.5 Abcam Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 PECAM-1 Antibody Value Chain Analysis
  2. 9.1.1 PECAM-1 Antibody Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 PECAM-1 Antibody Production Mode & Process
  6. 9.2 PECAM-1 Antibody Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 PECAM-1 Antibody Distributors
  9. 9.2.3 PECAM-1 Antibody Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst